Prenetics Drops Bitcoin Buys to Supercharge IM8 Health Brand

Prenetics has ended its Bitcoin purchasing program to focus all resources on expanding its fast-growing health brand IM8, retaining its current Bitcoin holdings but halting further acquisitions.

Prenetics Global Limited has announced it will cease all Bitcoin purchases and shift its capital allocation strategy to focus exclusively on the growth of its consumer health brand, IM8. The company, which holds 510 Bitcoin valued at over $45 million, will retain these holdings as a treasury reserve asset but will not make further acquisitions. This decision, approved by the board, comes as IM8 has rapidly surpassed $100 million in annualized recurring revenue within 11 months of launch and is projected to generate $180–$200 million in revenue for fiscal year 2026. Prenetics remains financially robust, with over $70 million in cash and no debt, enabling it to fund IM8’s expansion—including product innovation, marketing, talent acquisition, and international growth—without external financing. The move reflects a broader trend of companies refocusing on core business areas amid a cooling cryptocurrency market. Prenetics aims to strengthen strategic clarity and align fully with shareholder priorities as it scales IM8 globally.